127 related articles for article (PubMed ID: 6761568)
1. High-dose cytosine arabinoside: clinical response to therapy in acute leukemia.
Early AP; Preisler HD; Higby DJ; Brecher M; Browman G; McBride JA
Med Pediatr Oncol; 1982; 10 Suppl 1():239-50. PubMed ID: 6761568
[No Abstract] [Full Text] [Related]
2. High-dose cytosine arabinoside in the initial treatment of acute leukemia.
Barnett MJ; Waxman JH; Richards MA; Ganesan TS; Bragman KS; Rohatiner AZ; Lister TA
Semin Oncol; 1985 Jun; 12(2 Suppl 3):133-8. PubMed ID: 3859927
[No Abstract] [Full Text] [Related]
3. Treatment of refractory acute leukaemia with high dose cytosine arabinoside.
Willemze R; Zwaan FE; Keuning JJ; Colpin G
Br J Haematol; 1982 Jul; 51(3):497-8. PubMed ID: 6954973
[No Abstract] [Full Text] [Related]
4. [Attempt at treatment of acute leukemias with cytosine-arabinoside according to Skipper's method].
Schwarzenberg L; Mathé G; Hayat M; de Vassal F; Amiel JL; Cattan A; Schneider M; Schlumberger JR; Rosenfeld C; Jasmin C
Nouv Rev Fr Hematol; 1969; 9(2):199-204. PubMed ID: 4239783
[No Abstract] [Full Text] [Related]
5. Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia.
Kantarjian HM; Estey EH; Plunkett W; Keating MJ; Walters RS; Iacoboni S; McCredie KB; Freireich EJ
Am J Med; 1986 Sep; 81(3):387-94. PubMed ID: 3463209
[TBL] [Abstract][Full Text] [Related]
6. High dose cytosine arabinoside in the management of refractory acute leukaemia.
Willemze R; Zwaan FE; Colpin G; Keuning JJ
Scand J Haematol; 1982 Aug; 29(2):141-6. PubMed ID: 6958004
[TBL] [Abstract][Full Text] [Related]
7. Sequential use of methotrexate, folinic acid, and cytosine arabinoside in the treatment of acute leukemia.
Greenberg ML; Waxman S
Eur J Cancer (1965); 1976 Aug; 12(8):617-23. PubMed ID: 1086210
[No Abstract] [Full Text] [Related]
8. Our experience with cytosine arabinoside in the treatment of acute haemoblastoses.
Janele J; Rosa L
Neoplasma; 1973; 20(4):403-11. PubMed ID: 4517058
[No Abstract] [Full Text] [Related]
9. Induction of remission with l-Asparaginase, cyclophosphamide, cytosine arabinoside, and prednisolone in adult patients with acute leukemia.
Gahrton G; Engstedt L; Franzén S; Gullbring B; Holm G; Höglund S; Killander A; Killander D; Lockner D; Mellstedt H; Palmblad J; Reizenstein P; Skarberg KO; Swedberg B; Udén AM
Cancer; 1974 Aug; 34(2):472-9. PubMed ID: 4527847
[No Abstract] [Full Text] [Related]
10. [Cytosine-arabinoside in the treatment of acute leukemias].
Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
[No Abstract] [Full Text] [Related]
11. Experience with intermediate- and high-dose cytosine arabinoside in relapsed and refractory acute leukaemia.
Willemze R; Fibbe WE; Zwaan FE
Neth J Med; 1983; 26(8):215-9. PubMed ID: 6580554
[No Abstract] [Full Text] [Related]
12. High-dose cytosine arabinoside in the treatment of childhood malignancies.
Lie SO; Slørdahl S
Semin Oncol; 1985 Jun; 12(2 Suppl 3):160-5. PubMed ID: 3859931
[No Abstract] [Full Text] [Related]
13. Central nervous system toxicity of high-dose cytosine arabinoside.
Barnett MJ; Richards MA; Ganesan TS; Waxman JH; Smith BF; Butler MG; Rohatiner AZ; Slevin ML; Lister TA
Semin Oncol; 1985 Jun; 12(2 Suppl 3):227-32. PubMed ID: 3925559
[No Abstract] [Full Text] [Related]
14. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cytosine arabinoside (ara-C) and high-dose ara-C in acute leukemia.
Zittoun R; Marie JP; Zittoun J; Marquet J; Haanen C
Semin Oncol; 1985 Jun; 12(2 Suppl 3):139-43. PubMed ID: 3859928
[No Abstract] [Full Text] [Related]
16. [Cytosine arabinoside in the therapy of acute leukoses].
Quaglino D; De Pasquale A; Curci G; Montero C; Piccinini L
Minerva Med; 1971 Jun; 62(45):2271-82. PubMed ID: 5281484
[No Abstract] [Full Text] [Related]
17. High-dose cytosine arabinoside in combination with mitoxantrone for the treatment of refractory acute myeloid and lymphoblastic leukemia.
Hiddemann W; Kreutzmann H; Straif K; Ludwig WD; Mertelsmann R; Planker M; Donhuijsen-Ant R; Lengfelder E; Arlin Z; Büchner T
Semin Oncol; 1987 Jun; 14(2 Suppl 1):73-7. PubMed ID: 3473685
[TBL] [Abstract][Full Text] [Related]
18. Experience with the use of cytosine arabinoside in adult acute leukaemia.
Brodie GN; Penny R
Med J Aust; 1970 Mar; 1(13):635-7. PubMed ID: 5267173
[No Abstract] [Full Text] [Related]
19. [Clinical use of cytosine arabinoside in childhood. II. Cytosine arabinoside in the prevention and therapy of leukemic meningosis].
Masi M; Paolucci P; Vivarelli F; Vecchi V
Minerva Pediatr; 1975 Sep; 27(30):1624-31. PubMed ID: 1058332
[No Abstract] [Full Text] [Related]
20. High-dose cytosine arabinoside: advances in clinical pharmacology and therapeutic results.
Woodruff RK; Wiley JS
Aust N Z J Med; 1983 Dec; 13(6):561-3. PubMed ID: 6586146
[No Abstract] [Full Text] [Related]
[Next] [New Search]
